Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Archives of Toxicology|December 5, 2023
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registriesInmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Marina Villanueva-Paz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2023
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registriesMiren García-Cortés, Aida Ortega-Alonso, Gonzalo Matilla-Cabello, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver diseaseRaúl J Andrade, M Isabel Lucena, Anabel Alonso, et al.
Gastroenterology|August 9, 2005
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year periodRaúl J Andrade, M Isabel Lucena, M Carmen Fernández, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Gastroenterology|December 10, 2022
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-ClavulanatePaola Nicoletti, Andrew Dellinger, Yi Ju Li, et al.
Journal of Hepatology|May 4, 2024
Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI networkAntonio Segovia-Zafra, Marina Villanueva-Paz, Ana Sofia Serras, et al.
Gastroenterology|January 22, 2019
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver InjuryElizabeth T Cirulli, Paola Nicoletti, Karen Abramson, et al.
Archives of Toxicology|March 24, 2021
Serious liver injury induced by Nimesulide: an international collaborative studyFernando Bessone, Nelia Hernandez, Manuel Mendizabal, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Archives of Toxicology|December 5, 2023
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registriesInmaculada Medina-Cáliz, Judith Sanabria-Cabrera, Marina Villanueva-Paz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2023
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registriesMiren García-Cortés, Aida Ortega-Alonso, Gonzalo Matilla-Cabello, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver diseaseRaúl J Andrade, M Isabel Lucena, Anabel Alonso, et al.
Gastroenterology|August 9, 2005
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year periodRaúl J Andrade, M Isabel Lucena, M Carmen Fernández, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Gastroenterology|December 10, 2022
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-ClavulanatePaola Nicoletti, Andrew Dellinger, Yi Ju Li, et al.
Journal of Hepatology|May 4, 2024
Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI networkAntonio Segovia-Zafra, Marina Villanueva-Paz, Ana Sofia Serras, et al.
Gastroenterology|January 22, 2019
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver InjuryElizabeth T Cirulli, Paola Nicoletti, Karen Abramson, et al.
Archives of Toxicology|March 24, 2021
Serious liver injury induced by Nimesulide: an international collaborative studyFernando Bessone, Nelia Hernandez, Manuel Mendizabal, et al.
Pageof 16